FDA approves prostate cancer drug delivery system
May 8th 2008The FDA has approved Mixject, a new delivery system for triptorelin pamoate (Trelstar), a palliative treatment for advanced prostate cancer. Mixject combines triptorelin depot, 3.75 mg, and long-acting triptorelin, 11.25 mg, with new features that make preparation, administration, and disposal easier, according to Watson Pharmaceuticals, the manufactuer of triptorelin.
Pesticide exposure may increase testicular tumor risk
May 8th 2008Exposure to endocrine-disrupting chemicals, such as persistent organochlorine pesticides, is associated with the risk of both seminomatous and nonseminomatous testicular germ cell tumors, whereas exposure to chlordane compounds and metabolites may be associated with the risk of seminoma, according to a study published in an online issue of the Journal of the National Cancer Institute (April 28).
Cancer survivors have low levels of physical activity
May 8th 2008A new study reveals that many cancer survivors are inactive and obese, which may negatively affect the control of their disease. The findings, which come from a study of cancer survivors in Canada, show that a cancer diagnosis does not appear to prompt significant behavior change and that interventions to increase physical activity and promote better eating habits among cancer survivors are warranted.
Biomarker predicts malignancy potential of prostate lesions
May 8th 2008Spanish researchers have found a means of distinguishing between high-grade prostatic intraepithelial neoplasia (HGPIN) lesions destined to become cancerous and those that will remain benign, which may spare patients the discomfort and inconvenience of unnecessary needle biopsies, according to a study in Clinical Cancer Research (2008; 14:2617-22).
Management of postoperative ileus
May 1st 2008Postoperative ileus is a common result after major abdominal surgery, and frequently resolves within days after surgery. However, prolongedileus can result in increased pain and morbidity and increased time to hospital discharge. A multimodal approach using preventive and therapeutic strategies can definitively mange postoperative ileus.
July Medicare pay cut takes top priority at urology advocacy conference
May 1st 2008Against a backdrop of impending reductions in Medicare fees and warnings that a funding crisis looms, urology professionals from across America descended on Capitol Hill recently, determined to stand up for themselves and their profession.
Management of postoperative ileus
May 1st 2008Postoperative ileus is a common result after major abdominal surgery, and frequently resolves within days after surgery. However, prolonged ileus can result in increased pain and morbidity and increased time to hospital discharge. A multimodal approach using preventive and therapeutic strategies can definitively mange postoperative ileus.
Intraoperative TRUS monitoring during laparoscopic radical prostatectomy: Clinical advantages
May 1st 2008In potent, young patients diagnosed with clinically localized prostate cancer, sparing of the neurovascular bundles during radical prostatectomy is crucial for preservation of erectile function. Intraoperative ultrasound monitoring, combined with preoperative oncologic data, can greatly improve outcomes. Novel, emerging techniques and ultrasound-driven imaging technologies may further advance the practice of nerve preservation.